← Back to headlines
Alnylam Pharmaceuticals Advances Diabetes Drug into Phase 2 Clinical Trial
Alnylam Pharmaceuticals announced that its experimental drug for diabetes has progressed to a Phase 2 clinical trial, marking a significant step in its development.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
